Biotechnology Fund Three Year Return vs. Minimum Initial Investment

RYBOX Fund  USD 68.28  0.33  0.49%   
Based on the measurements of profitability obtained from Biotechnology Fund's financial statements, Biotechnology Fund Class may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Biotechnology Fund's ability to earn profits and add value for shareholders.
For Biotechnology Fund profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotechnology Fund to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotechnology Fund Class utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotechnology Fund's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotechnology Fund Class over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Biotechnology Fund's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Fund is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Fund's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Fund Class Minimum Initial Investment vs. Three Year Return Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Fund's current stock value. Our valuation model uses many indicators to compare Biotechnology Fund value to that of its competitors to determine the firm's financial worth.
Biotechnology Fund Class is rated top fund in three year return among similar funds. It also is rated top fund in minimum initial investment among similar funds . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Fund's earnings, one of the primary drivers of an investment's value.

Biotechnology Minimum Initial Investment vs. Three Year Return

Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

Biotechnology Fund

Three Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
(0.45) %
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.

Biotechnology Fund

Minimum Initial Investment

=

First Fund Deposit

 = 
2.5 K
Fund managers put minimum investment restrictions on fund investments in order to allow the fund to function properly. Minimum restrictions allow fund managers to regulate cash flows of the fund, while guarding it against random trades that may negatively affect fund strategy.

Biotechnology Minimum Initial Investment Comparison

Biotechnology Fund is currently under evaluation in minimum initial investment among similar funds.

Biotechnology Fund Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biotechnology Fund, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotechnology Fund will eventually generate negative long term returns. The profitability progress is the general direction of Biotechnology Fund's change in net profit over the period of time. It can combine multiple indicators of Biotechnology Fund, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Biotechnology Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biotechnology Fund. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotechnology Fund position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotechnology Fund's important profitability drivers and their relationship over time.

Use Biotechnology Fund in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotechnology Fund position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will appreciate offsetting losses from the drop in the long position's value.

Biotechnology Fund Pair Trading

Biotechnology Fund Class Pair Trading Analysis

The ability to find closely correlated positions to Biotechnology Fund could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotechnology Fund when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotechnology Fund - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotechnology Fund Class to buy it.
The correlation of Biotechnology Fund is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotechnology Fund moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotechnology Fund Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotechnology Fund can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biotechnology Fund position

In addition to having Biotechnology Fund in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Office Supplies Thematic Idea Now

Office Supplies
Office Supplies Theme
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Biotechnology Mutual Fund

To fully project Biotechnology Fund's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotechnology Fund Class at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotechnology Fund's income statement, its balance sheet, and the statement of cash flows.
Potential Biotechnology Fund investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biotechnology Fund investors may work on each financial statement separately, they are all related. The changes in Biotechnology Fund's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotechnology Fund's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings